Arca
Skip to content

Reaads Anti-Cardiolipin Igg/Igm Semi-Quantitative Test Kit, Model 023-001

System, Test, Anticardiolipin Immunological. 510(k) K022992, from Corgenix, Inc. (Westminster, CO). Product code MID, class 2.

As of Nov 17, 2026, K022992 is an FDA 510(k) held by Corgenix, Inc., substantially equivalent on Sep 25, 2002 after 16 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Sep 25, 2002
  • Review time: 16 days
  • Recalls: 0
  • Cited as a predicate by: 3 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

An enzyme-linked immunosorbent assay (ELISA) for the determination of IgG and IgM anti-cardiolipin antibodies in human serum or plasma. For the detection and semi-quantitation of anti-cardiolipin antibodies in individuals with systemic lupus erythematosus (SLE) and lupus-like disorders (anti-phospholipid syndrome).

Cited as a Predicate

3 later 510(k) summaries name this device as a predicate

Other MID Clearances

The newest 510(k)s for the same product code; see every MID device

Record

Type
Special
Received
Sep 9, 2002
Review panel
Immunology
Regulation
21 CFR 866.5660

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.